Literature DB >> 7779415

Analysis of the effects of oxygen supply and demand on hypoxic fraction in tumors.

T W Secomb1, R Hsu, E T Ong, J F Gross, M W Dewhirst.   

Abstract

The extent of hypoxic regions in a tumor tissue depends on the arrangement, blood flow rate and blood oxygen content of microvessels, and on the tissue's oxygen consumption rate. Here, the effects of blood flow rate, blood oxygen content and oxygen consumption on hypoxic fraction are simulated theoretically, for a region whose microvascular geometry was derived from observations of a transplanted mammary andenocarcinoma (R3230AC) in a rat dorsal skin flap preparation. In the control state, arterial PO2 is 100 mmHg, consumption rate is 2.4 cm3 O2/100 g/min, and hypoxic fraction (tissue with PO2 < 3 mmHg) is 30%. Hypoxia is abolished by a reduction in consumption rate of at least 30%, relative to control, or an increase in flow rate by a factor of 4 or more, or an increase in arterial PO2 by a factor of 11 or more. These results suggest that reducing oxygen consumption rate may be more effective than elevating blood flow or oxygen content as a method to reduce tumor hypoxia.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7779415     DOI: 10.3109/02841869509093981

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  77 in total

Review 1.  Causes and effects of heterogeneous perfusion in tumors.

Authors:  R J Gillies; P A Schornack; T W Secomb; N Raghunand
Journal:  Neoplasia       Date:  1999-08       Impact factor: 5.715

Review 2.  Exercise as Adjunct Therapy in Cancer.

Authors:  Kathleen A Ashcraft; Allison Betof Warner; Lee W Jones; Mark W Dewhirst
Journal:  Semin Radiat Oncol       Date:  2019-01       Impact factor: 5.934

Review 3.  The microcirculation: physiology at the mesoscale.

Authors:  Timothy W Secomb; Axel R Pries
Journal:  J Physiol       Date:  2011-01-17       Impact factor: 5.182

4.  A potential solution for eliminating hypoxia as a cause for radioresistance.

Authors:  Mark W Dewhirst
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-09       Impact factor: 11.205

5.  The PI3K/Akt Pathway Regulates Oxygen Metabolism via Pyruvate Dehydrogenase (PDH)-E1α Phosphorylation.

Authors:  George J Cerniglia; Souvik Dey; Shannon M Gallagher-Colombo; Natalie A Daurio; Stephen Tuttle; Theresa M Busch; Alexander Lin; Ramon Sun; Tatiana V Esipova; Sergei A Vinogradov; Nicholas Denko; Constantinos Koumenis; Amit Maity
Journal:  Mol Cancer Ther       Date:  2015-05-20       Impact factor: 6.261

Review 6.  Redox-modulated phenomena and radiation therapy: the central role of superoxide dismutases.

Authors:  Aaron K Holley; Lu Miao; Daret K St Clair; William H St Clair
Journal:  Antioxid Redox Signal       Date:  2014-02-14       Impact factor: 8.401

7.  Oxygen consumption can regulate the growth of tumors, a new perspective on the Warburg effect.

Authors:  Yijun Chen; Rob Cairns; Ioanna Papandreou; Albert Koong; Nicholas C Denko
Journal:  PLoS One       Date:  2009-09-15       Impact factor: 3.240

8.  Gaussian mixture model-based classification of dynamic contrast enhanced MRI data for identifying diverse tumor microenvironments: preliminary results.

Authors:  S H Han; E Ackerstaff; R Stoyanova; S Carlin; W Huang; J A Koutcher; J K Kim; G Cho; G Jang; H Cho
Journal:  NMR Biomed       Date:  2013-02-25       Impact factor: 4.044

9.  Dynamic contrast-enhanced magnetic resonance imaging as a predictor of clinical outcome in canine spontaneous soft tissue sarcomas treated with thermoradiotherapy.

Authors:  Benjamin L Viglianti; Michael Lora-Michiels; Jeanie M Poulson; Lan Lan; Daohai Yu; Dahio Yu; Linda Sanders; Oana Craciunescu; Zeljko Vujaskovic; Donald E Thrall; James Macfall; Cecil H Charles; Terence Wong; Mark W Dewhirst
Journal:  Clin Cancer Res       Date:  2009-07-21       Impact factor: 12.531

10.  Microenvironmental adaptation of experimental tumours to chronic vs acute hypoxia.

Authors:  O Thews; T Wolloscheck; W Dillenburg; S Kraus; D K Kelleher; M A Konerding; P Vaupel
Journal:  Br J Cancer       Date:  2004-09-13       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.